Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2000 Jul;106(2):171-6.
doi: 10.1172/JCI10583.

Cellular mechanisms of insulin resistance

G I Shulman  1
Affiliations
Review

Cellular mechanisms of insulin resistance

G I Shulman. J Clin Invest. 2000 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Potential rate-controlling steps responsible for reduced insulin-stimulated muscle glycogen synthesis in patients with type 2 diabetes mellitus. UDP, uridine diphosphate.
Figure 2
Figure 2
Top: Mechanism of fatty acid–induced insulin resistance in skeletal muscle as proposed by Randle et al. An increase in fatty acid concentration results in an elevation of the intramitochondrial acetyl CoA/CoA and NADH/NAD+ ratios, with subsequent inactivation of pyruvate dehydrogenase. This in turn causes citrate concentrations to increase, leading to inhibition of phosphofructokinase. Subsequent increases in intracellular glucose-6-phosphate concentration would inhibit hexokinase II activity, which would result in an increase in intracellular glucose concentration and a decrease in muscle glucose uptake. Bottom: Proposed alternative mechanism for fatty acid–induced insulin resistance in human skeletal muscle. An increase in delivery of fatty acids to muscle or a decrease in intracellular metabolism of fatty acids leads to an increase in intracellular fatty acid metabolites such as diacylglycerol, fatty acyl CoA, and ceramides. These metabolites activate a serine/threonine kinase cascade (possibly initiated by protein kinase Cθ) leading to phosphorylation of serine/threonine sites on insulin receptor substrates (IRS-1 and IRS-2), which in turn reduces the ability of the insulin receptor substrates to activate PI 3-kinase. As a consequence, glucose transport activity and other events downstream of insulin receptor signaling are diminished. HK, hexokinase II; PFK, phosphofructokinase; PDH, pyruvate dehydrogenase; PKCθ, protein kinase Cθ.
See this image and copyright information in PMC

References

    1. O’Rahilly S. Science, medicine, and the future. Non-insulin dependent diabetes mellitus: the gathering storm. BMJ. 1997;314:955–959. - PMC - PubMed
    1. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic patients. Ann Intern Med. 1990;113:909–915. - PubMed
    1. Lillioja S, et al. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med. 1988;318:1217–1225. - PubMed
    1. Haffner SM, et al. Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. Metabolism. 1990;39:842–847. - PubMed
    1. Reaven GM, Bernstein R, Davis B, Olefsky JM. Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med. 1976;60:80–88. - PubMed

Publication types